KLHL26
geneOn this page
Summary
KLHL26 (kelch like family member 26, HGNC:25623) is a protein-coding gene on chromosome 19p13.11, encoding Kelch-like protein 26 (Q53HC5). May play a role in endo(sarco)plasmic reticulum (ER/SR) mitochondrial signaling.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 108 total
- Druggable target: yes
- MANE Select transcript:
NM_018316
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25623 |
| Approved symbol | KLHL26 |
| Name | kelch like family member 26 |
| Location | 19p13.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000167487 |
| Ensembl biotype | protein_coding |
| Entrez | 55295 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 4 protein_coding, 1 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000300976, ENST00000595182, ENST00000595423, ENST00000596843, ENST00000599006, ENST00000600657
RefSeq mRNA: 6 — MANE Select: NM_018316
NM_001345981, NM_001345982, NM_001345983, NM_001345984, NM_001345985, NM_018316
CCDS: CCDS12384, CCDS86726, CCDS86727
Canonical transcript exons
ENST00000300976 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001123057 | 18667664 | 18671721 |
| ENSE00001183319 | 18637028 | 18637137 |
| ENSE00003555092 | 18664261 | 18664443 |
Expression profiles
Bgee: expression breadth ubiquitous, 211 present calls, max score 93.99.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.8922 / max 62.5457, expressed in 1626 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 174714 | 4.2645 | 1561 |
| 174715 | 0.6277 | 333 |
Top tissues by expression
272 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| secondary oocyte | CL:0000655 | 93.99 | gold quality |
| oocyte | CL:0000023 | 93.81 | gold quality |
| popliteal artery | UBERON:0002250 | 89.44 | gold quality |
| tibial artery | UBERON:0007610 | 89.41 | gold quality |
| aorta | UBERON:0000947 | 85.09 | gold quality |
| prefrontal cortex | UBERON:0000451 | 83.37 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 81.86 | gold quality |
| right frontal lobe | UBERON:0002810 | 81.79 | gold quality |
| frontal cortex | UBERON:0001870 | 81.64 | gold quality |
| postcentral gyrus | UBERON:0002581 | 81.32 | gold quality |
| left coronary artery | UBERON:0001626 | 81.29 | gold quality |
| cortical plate | UBERON:0005343 | 80.86 | gold quality |
| neocortex | UBERON:0001950 | 80.84 | gold quality |
| coronary artery | UBERON:0001621 | 80.45 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 80.17 | gold quality |
| entorhinal cortex | UBERON:0002728 | 80.13 | gold quality |
| nucleus accumbens | UBERON:0001882 | 80.01 | gold quality |
| caudate nucleus | UBERON:0001873 | 80.00 | gold quality |
| gastrocnemius | UBERON:0001388 | 79.94 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 79.67 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 79.60 | gold quality |
| cingulate cortex | UBERON:0003027 | 79.56 | gold quality |
| thoracic aorta | UBERON:0001515 | 79.55 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 79.53 | gold quality |
| ascending aorta | UBERON:0001496 | 79.52 | gold quality |
| cerebral cortex | UBERON:0000956 | 79.46 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 79.37 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 79.37 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 79.14 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 79.12 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.56 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
61 targeting KLHL26, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-12118 | 100.00 | 65.88 | 1270 |
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-4481 | 100.00 | 66.42 | 1669 |
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-6891-5P | 99.98 | 66.53 | 1372 |
| HSA-MIR-3173-3P | 99.98 | 66.49 | 1217 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-185-3P | 99.95 | 67.01 | 1743 |
| HSA-MIR-497-5P | 99.92 | 71.83 | 2674 |
| HSA-MIR-15A-5P | 99.90 | 72.80 | 2787 |
| HSA-MIR-15B-5P | 99.90 | 72.78 | 2798 |
| HSA-MIR-16-5P | 99.90 | 72.80 | 2780 |
| HSA-MIR-195-5P | 99.90 | 72.81 | 2805 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-424-5P | 99.89 | 71.90 | 2641 |
| HSA-MIR-6838-5P | 99.89 | 71.94 | 2690 |
| HSA-MIR-4779 | 99.86 | 66.50 | 1583 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-765 | 99.84 | 68.24 | 2442 |
| HSA-MIR-1321 | 99.84 | 65.30 | 1811 |
| HSA-MIR-4739 | 99.84 | 65.25 | 1832 |
| HSA-MIR-4756-5P | 99.84 | 64.98 | 1809 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-4639-5P | 99.81 | 67.37 | 1028 |
| HSA-MIR-11181-3P | 99.75 | 66.38 | 2205 |
| HSA-MIR-3913-3P | 99.74 | 66.53 | 938 |
| HSA-MIR-4524A-3P | 99.72 | 66.85 | 2406 |
Literature-anchored findings (GeneRIF, showing 1)
- Novel KLHL26 variant associated with a familial case of Ebstein’s anomaly and left ventricular noncompaction. (PMID:31985165)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | klhl26 | ENSDARG00000053876 |
| mus_musculus | Klhl26 | ENSMUSG00000055707 |
| rattus_norvegicus | Klhl26 | ENSRNOG00000020088 |
Paralogs (54): KLHL13 (ENSG00000003096), KLHL20 (ENSG00000076321), KEAP1 (ENSG00000079999), KLHL42 (ENSG00000087448), KLHL22 (ENSG00000099910), KLHL4 (ENSG00000102271), KLHL2 (ENSG00000109466), KLHL5 (ENSG00000109790), BACH2 (ENSG00000112182), KLHL18 (ENSG00000114648), KLHL24 (ENSG00000114796), IVNS1ABP (ENSG00000116679), KLHL12 (ENSG00000117153), KLHL29 (ENSG00000119771), KBTBD7 (ENSG00000120696), KLHL7 (ENSG00000122550), KLHL31 (ENSG00000124743), KLHDC7B (ENSG00000130487), KLHL36 (ENSG00000135686), KLHL8 (ENSG00000145332), KLHL3 (ENSG00000146021), KLHL35 (ENSG00000149243), KLHL1 (ENSG00000150361), BACH1 (ENSG00000156273), KLHL40 (ENSG00000157119), KLHL10 (ENSG00000161594), KLHL21 (ENSG00000162413), KLHDC8A (ENSG00000162873), KBTBD8 (ENSG00000163376), KBTBD6 (ENSG00000165572), KLHL30 (ENSG00000168427), KBTBD2 (ENSG00000170852), KLHL6 (ENSG00000172578), KLHL15 (ENSG00000174010), KLHL38 (ENSG00000175946), KBTBD11 (ENSG00000176595), KLHDC7A (ENSG00000179023), KLHL28 (ENSG00000179454), KBTBD3 (ENSG00000182359), KLHL33 (ENSG00000185271)
Protein
Protein identifiers
Kelch-like protein 26 — Q53HC5 (reviewed: Q53HC5)
All UniProt accessions (5): Q53HC5, M0QXE1, M0R049, M0R1N0, M0R1P3
UniProt curated annotations — full annotation on UniProt →
Function. May play a role in endo(sarco)plasmic reticulum (ER/SR) mitochondrial signaling. May be part of the ubiquitin-proteasome system (UPS) and affect ubiquitination and degradation of target substrates in cardiomyocytes.
Disease relevance. Defects in KLHL26 may be cause of autosomal dominant inheritance of Ebstein’s anomaly and left ventricular non-compaction.
RefSeq proteins (5): NP_001332910, NP_001332911, NP_001332913, NP_001332914, NP_060786* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000210 | BTB/POZ_dom | Domain |
| IPR006652 | Kelch_1 | Repeat |
| IPR011333 | SKP1/BTB/POZ_sf | Homologous_superfamily |
| IPR011705 | BACK | Domain |
| IPR015915 | Kelch-typ_b-propeller | Homologous_superfamily |
| IPR017096 | BTB-kelch_protein | Family |
| IPR030588 | BTB_POZ_KLHL26 | Domain |
Pfam: PF00651, PF01344, PF07707
UniProt features (30 total): helix 7, strand 6, repeat 6, sequence variant 2, domain 2, initiator methionine 1, chain 1, region of interest 1, compositionally biased region 1, modified residue 1, sequence conflict 1, turn 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 9ETW | X-RAY DIFFRACTION | 1.51 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q53HC5-F1 | 91.98 | 0.85 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 2
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 75 (showing top):
GSE45365_NK_CELL_VS_CD11B_DC_UP, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5, GOBP_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS, GOBP_PROTEIN_CATABOLIC_PROCESS, GOCC_TRANSFERASE_COMPLEX, GOBP_PROTEOLYSIS, GOCC_CULLIN_RING_UBIQUITIN_LIGASE_COMPLEX, GOCC_CUL3_RING_UBIQUITIN_LIGASE_COMPLEX, chr19p13, RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN, GOCC_UBIQUITIN_LIGASE_COMPLEX, KOYAMA_SEMA3B_TARGETS_DN, LINSLEY_MIR16_TARGETS, NOTCH_DN.V1_UP
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
726 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KLHL26 | CIMAP1D | Q3SX64 | 591 |
| KLHL26 | OR2A12 | Q8NGT7 | 574 |
| KLHL26 | ERICH3 | Q5RHP9 | 543 |
| KLHL26 | CIB3 | Q96Q77 | 516 |
| KLHL26 | PLCD4 | Q9BRC7 | 488 |
| KLHL26 | SAXO2 | Q658L1 | 466 |
| KLHL26 | NEB | P20929 | 445 |
| KLHL26 | QPCT | Q16769 | 415 |
| KLHL26 | SPDYC | Q5MJ68 | 404 |
| KLHL26 | DNAJC5B | Q9UF47 | 403 |
| KLHL26 | NEDD8 | Q15843 | 391 |
| KLHL26 | NUP210L | Q5VU65 | 387 |
| KLHL26 | MCMDC2 | Q4G0Z9 | 379 |
| KLHL26 | CCDC63 | Q8NA47 | 361 |
| KLHL26 | ATP8A1 | Q9Y2Q0 | 357 |
IntAct
145 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KLHL9 | CUL3 | psi-mi:“MI:0914”(association) | 0.860 |
| KLHL12 | KLHL2 | psi-mi:“MI:0914”(association) | 0.850 |
| COPS6 | RHOBTB1 | psi-mi:“MI:0914”(association) | 0.730 |
| KLHL26 | CUL3 | psi-mi:“MI:0914”(association) | 0.730 |
| KLHL24 | CUL3 | psi-mi:“MI:0914”(association) | 0.730 |
| FBXL17 | BACH1 | psi-mi:“MI:0914”(association) | 0.730 |
| CFTR | ESYT2 | psi-mi:“MI:0914”(association) | 0.710 |
| KLHL13 | COPS2 | psi-mi:“MI:0914”(association) | 0.640 |
| KLHL22 | TMEM223 | psi-mi:“MI:0914”(association) | 0.640 |
| KLHL21 | CUL3 | psi-mi:“MI:0914”(association) | 0.640 |
| KLHL25 | ENC1 | psi-mi:“MI:0914”(association) | 0.640 |
| KLHL22 | METTL15 | psi-mi:“MI:0914”(association) | 0.640 |
| ANKS1A | KLHL26 | psi-mi:“MI:0915”(physical association) | 0.560 |
| AQP1 | KLHL26 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KLHL26 | ENKD1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KLHL26 | NUDT22 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZIC1 | KLHL26 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PITX1 | KLHL26 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRR35 | KLHL26 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FOXH1 | KLHL26 | psi-mi:“MI:0915”(physical association) | 0.560 |
| OTX1 | KLHL26 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KLHL26 | KCTD9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| POGZ | KLHL26 | psi-mi:“MI:0915”(physical association) | 0.560 |
| INCA1 | KLHL26 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TARDBP | KLHL26 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (127): KLHL26 (Affinity Capture-MS), KLHL26 (Affinity Capture-MS), KLHL26 (Affinity Capture-MS), KLHL26 (Affinity Capture-MS), KLHL26 (Affinity Capture-MS), KLHL26 (Affinity Capture-MS), KLHL26 (Affinity Capture-MS), KLHL26 (Affinity Capture-MS), KLHL26 (Affinity Capture-MS), KLHL26 (Affinity Capture-MS), KLHL26 (Affinity Capture-MS), KLHL26 (Affinity Capture-MS), KLHL26 (Affinity Capture-MS), KLHL26 (Affinity Capture-MS), KLHL26 (Affinity Capture-MS)
ESM2 similar proteins: A0A2R8Q1W5, B0WWP2, B3M9V8, B3NDN0, B4GRJ2, B4HIK1, B4J045, B4L0G9, B4LIG6, B4MXW3, B4PD06, B4QLQ2, D3Z8N4, E9Q4F2, O14682, O35709, O94889, P28575, P59280, Q08BL9, Q08DK3, Q0D2A9, Q16RL8, Q1ECZ2, Q1LYM6, Q2M0J9, Q4KLM4, Q53HC5, Q56A24, Q5R7B8, Q5RGB8, Q5ZKD9, Q6DFF6, Q6DFF7, Q6TDP3, Q6TDP4, Q6TFL4, Q6V595, Q7QGL0, Q8BRG6
Diamond homologs: A0A0A6YY25, B2RXH4, E0CZ16, E1B932, E7F6F9, F1LZ52, F1LZF0, F1MBP6, O88282, O93567, O95198, P10074, P17789, P42282, P42283, P42284, Q01295, Q1H9T6, Q24174, Q24206, Q3B7M1, Q52KG4, Q53G59, Q53HC5, Q5R633, Q5REP9, Q5U374, Q66HD2, Q6NRH0, Q7KQZ4, Q7KRI2, Q867Z4, Q86B87, Q8BGY4, Q8BZM0, Q8CA72, Q8IN81, Q8JZP3, Q8K0L9, Q8N143
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 128 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Neddylation | 17 | 10.1× | 3e-10 |
| Class I MHC mediated antigen processing & presentation | 10 | 8.8× | 4e-05 |
| Antigen processing: Ubiquitination & Proteasome degradation | 11 | 5.1× | 1e-03 |
| Adaptive Immune System | 11 | 4.1× | 4e-03 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| protein monoubiquitination | 5 | 14.8× | 3e-03 |
| protein ubiquitination | 20 | 7.1× | 4e-09 |
| protein folding | 8 | 7.1× | 3e-03 |
| proteasome-mediated ubiquitin-dependent protein catabolic process | 15 | 6.8× | 2e-06 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
108 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 98 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
680 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:18637134:ACAGG:A | donor_loss | 1.0000 |
| 19:18637135:CAGGT:C | donor_loss | 1.0000 |
| 19:18637136:AGGTG:A | donor_loss | 1.0000 |
| 19:18637137:GGTGA:G | donor_loss | 1.0000 |
| 19:18637138:GTGA:G | donor_loss | 1.0000 |
| 19:18637139:T:G | donor_loss | 1.0000 |
| 19:18664259:A:AG | acceptor_gain | 1.0000 |
| 19:18664259:AGCAC:A | acceptor_gain | 1.0000 |
| 19:18664260:G:GG | acceptor_gain | 1.0000 |
| 19:18664260:GCAC:G | acceptor_gain | 1.0000 |
| 19:18664260:GCACG:G | acceptor_gain | 1.0000 |
| 19:18664440:TCAGG:T | donor_loss | 1.0000 |
| 19:18664441:CAG:C | donor_gain | 1.0000 |
| 19:18664441:CAGGT:C | donor_loss | 1.0000 |
| 19:18664442:AG:A | donor_gain | 1.0000 |
| 19:18664442:AGGT:A | donor_loss | 1.0000 |
| 19:18664443:GG:G | donor_gain | 1.0000 |
| 19:18664443:GGT:G | donor_loss | 1.0000 |
| 19:18664444:G:GG | donor_gain | 1.0000 |
| 19:18659668:T:A | acceptor_gain | 0.9900 |
| 19:18659669:G:A | acceptor_gain | 0.9900 |
| 19:18664257:GCA:G | acceptor_loss | 0.9900 |
| 19:18664258:CA:C | acceptor_loss | 0.9900 |
| 19:18664260:GC:G | acceptor_gain | 0.9900 |
| 19:18664260:GCA:G | acceptor_gain | 0.9900 |
| 19:18664439:TTCAG:T | donor_gain | 0.9900 |
| 19:18664440:TCAG:T | donor_gain | 0.9900 |
| 19:18667658:CTTCA:C | acceptor_loss | 0.9900 |
| 19:18667659:TTCA:T | acceptor_loss | 0.9900 |
| 19:18667660:TCA:T | acceptor_loss | 0.9900 |
AlphaMissense
4004 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:18669159:T:A | W588R | 1.000 |
| 19:18669159:T:C | W588R | 1.000 |
| 19:18669161:G:C | W588C | 1.000 |
| 19:18669161:G:T | W588C | 1.000 |
| 19:18664430:A:C | S85R | 0.999 |
| 19:18664432:C:A | S85R | 0.999 |
| 19:18664432:C:G | S85R | 0.999 |
| 19:18668604:C:A | R403S | 0.999 |
| 19:18668613:T:C | F406L | 0.999 |
| 19:18668615:C:A | F406L | 0.999 |
| 19:18668615:C:G | F406L | 0.999 |
| 19:18668715:T:A | W440R | 0.999 |
| 19:18668715:T:C | W440R | 0.999 |
| 19:18668717:G:C | W440C | 0.999 |
| 19:18668717:G:T | W440C | 0.999 |
| 19:18668859:T:A | W488R | 0.999 |
| 19:18668859:T:C | W488R | 0.999 |
| 19:18668861:G:C | W488C | 0.999 |
| 19:18668861:G:T | W488C | 0.999 |
| 19:18668938:G:A | G514E | 0.999 |
| 19:18668941:G:A | G515D | 0.999 |
| 19:18669012:T:A | W539R | 0.999 |
| 19:18669012:T:C | W539R | 0.999 |
| 19:18669014:G:C | W539C | 0.999 |
| 19:18669014:G:T | W539C | 0.999 |
| 19:18669091:G:A | G565E | 0.999 |
| 19:18669138:T:G | Y581D | 0.999 |
| 19:18664422:C:A | A82D | 0.998 |
| 19:18667755:T:C | F120L | 0.998 |
| 19:18667757:C:A | F120L | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000018416 (19:18639933 G>A,C), RS1000052547 (19:18656620 G>A,T), RS1000100033 (19:18662260 C>G,T), RS1000143534 (19:18642996 A>G), RS1000220741 (19:18658300 G>A,T), RS1000257590 (19:18662023 G>A), RS1000285108 (19:18639275 A>G), RS1000566319 (19:18644840 C>T), RS1000585111 (19:18639602 G>T), RS1000587829 (19:18650516 T>C), RS1000619013 (19:18650661 G>A), RS1000698529 (19:18666040 G>A), RS1000797040 (19:18670931 T>C,G), RS1000828180 (19:18670672 G>A,T), RS1000936893 (19:18644645 T>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST008832_21 | Gastroesophageal reflux disease | 2.000000e-09 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL6196098 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
18 total (human), top 18 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases methylation, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| trichostatin A | affects expression | 1 |
| sodium arsenite | increases expression | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| potassium chromate(VI) | affects cotreatment, increases expression | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| epigallocatechin gallate | affects cotreatment, increases expression | 1 |
| abrine | increases expression | 1 |
| (+)-JQ1 compound | increases expression | 1 |
| Atrazine | increases expression | 1 |
| Doxorubicin | increases expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Smoke | decreases expression | 1 |
| Testosterone | increases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Acrylamide | increases expression | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL6096342 | Binding | Binding affinity to human KLHL26 BTB domain (34 to 161 residues) extracted from Escherichia coli BL21(DE3)-R3-pRARE2 cells assessed as adduct formation at 100 uM by LC-MS analysis | Covalent Inhibitors of KEAP1 with Exquisite Selectivity. — J Med Chem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): gastroesophageal reflux disease